Blue Bird Corp.
Congress has disclosed 0 buys and 1 sell of BLBD (Blue Bird Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
1 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Julie Johnson | House | SELL ◆ insider divergence · moderate | Joint · Merrill Lynch Long Term Growth | 2025-04-07 | 29 days | +19.5% | $1K–$15K <0.1% of NW |
62.6 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in BLBD — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in BLBD, 0 coincided with corporate insiders moving the same way within 60 days, and 1 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-09-16 | Sanfrey Jeffrey Scott | C-suite | SELL | $250K | ↗ EDGAR |
| 2026-08-12 | Thau Daniel Mark | Director | BUY | $23K | ↗ EDGAR |
| 2026-05-19 | Thau Daniel Mark | Director | BUY | $20K | ↗ EDGAR |
| 2026-03-04 | Sanfrey Jeffrey Scott | C-suite | SELL | $304K | ↗ EDGAR |
| 2026-02-19 | Radulescu Razvan | C-suite | SELL | $239K | ↗ EDGAR |
| 2025-12-17 | Radulescu Razvan | C-suite | SELL 10b5-1 | $361K | ↗ EDGAR |
| 2025-12-12 | Horlock Phil | Director | SELL | $356K | ↗ EDGAR |
| 2025-12-12 | Horlock Phil | Director | SELL | $420K | ↗ EDGAR |
| 2025-12-10 | Radulescu Razvan | C-suite | SELL 10b5-1 | $402K | ↗ EDGAR |
| 2025-12-04 | Thau Daniel Mark | Director | BUY | $20K | ↗ EDGAR |
| 2025-09-12 | Horlock Phil | Director | SELL | $788K | ↗ EDGAR |
| 2025-09-02 | Radulescu Razvan | C-suite | SELL | $385K | ↗ EDGAR |
| 2025-08-28 | Horlock Phil | Director | SELL | $767K | ↗ EDGAR |
| 2025-08-18 | Horlock Phil | Director | SELL | $1.2M | ↗ EDGAR |
| 2025-08-15 | Horlock Phil | Director | SELL | $1.2M | ↗ EDGAR |
| 2025-08-13 | Horlock Phil | Director | SELL | $888K | ↗ EDGAR |
| 2025-08-12 | Scartz Ted | Other | SELL | $490K | ↗ EDGAR |
| 2025-08-08 | Horlock Phil | Director | SELL 10b5-1 | $1.8M | ↗ EDGAR |
| 2025-08-08 | Radulescu Razvan | C-suite | SELL 10b5-1 | $42K | ↗ EDGAR |
| 2025-08-07 | Radulescu Razvan | C-suite | SELL 10b5-1 | $532K | ↗ EDGAR |
| 2025-07-08 | Radulescu Razvan | C-suite | SELL 10b5-1 | $452K | ↗ EDGAR |
| 2025-06-12 | Horlock Phil | Director | SELL | $616K | ↗ EDGAR |
| 2025-06-11 | Horlock Phil | Director | SELL | $184K | ↗ EDGAR |
| 2025-06-11 | Horlock Phil | Director | SELL | $370K | ↗ EDGAR |
| 2025-06-10 | Horlock Phil | Director | SELL | $364K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-09-16 | Sanfrey Jeffrey Scott C-suite | SELL | $250K |
| ◆ insider | 2026-08-12 | Thau Daniel Mark Director | BUY | $23K |
| ◆ insider | 2026-05-19 | Thau Daniel Mark Director | BUY | $20K |
| ◆ insider | 2026-03-04 | Sanfrey Jeffrey Scott C-suite | SELL | $304K |
| ◆ insider | 2026-02-19 | Radulescu Razvan C-suite | SELL | $239K |
| ◆ insider | 2025-12-17 | Radulescu Razvan C-suite 10b5-1 | SELL | $361K |
| ◆ insider | 2025-12-12 | Horlock Phil Director | SELL | $356K |
| ◆ insider | 2025-12-12 | Horlock Phil Director | SELL | $420K |
| ◆ insider | 2025-12-10 | Radulescu Razvan C-suite 10b5-1 | SELL | $402K |
| ◆ insider | 2025-12-04 | Thau Daniel Mark Director | BUY | $20K |
| ◆ insider | 2025-09-12 | Horlock Phil Director | SELL | $788K |
| ◆ insider | 2025-09-02 | Radulescu Razvan C-suite | SELL | $385K |
| ◆ insider | 2025-08-28 | Horlock Phil Director | SELL | $767K |
| ◆ insider | 2025-08-18 | Horlock Phil Director | SELL | $1.2M |
| ◆ insider | 2025-08-15 | Horlock Phil Director | SELL | $1.2M |
| ◆ insider | 2025-08-13 | Horlock Phil Director | SELL | $888K |
| ◆ insider | 2025-08-12 | Scartz Ted Other | SELL | $490K |
| ◆ insider | 2025-08-08 | Horlock Phil Director 10b5-1 | SELL | $1.8M |
| ◆ insider | 2025-08-08 | Radulescu Razvan C-suite 10b5-1 | SELL | $42K |
| ◆ insider | 2025-08-07 | Radulescu Razvan C-suite 10b5-1 | SELL | $532K |
| ◆ insider | 2025-07-08 | Radulescu Razvan C-suite 10b5-1 | SELL | $452K |
| ◆ insider | 2025-06-12 | Horlock Phil Director | SELL | $616K |
| ◆ insider | 2025-06-11 | Horlock Phil Director | SELL | $184K |
| ◆ insider | 2025-06-11 | Horlock Phil Director | SELL | $370K |
FAQ Common questions
How much has Congress traded BLBD?
0 disclosed buys and 1 sells of BLBD (Blue Bird Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade BLBD?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.